Related Experiment Video
Updated: May 21, 2026

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
Published on: April 11, 2025
The proline regulatory axis and cancer
James Ming Phang1, Wei Liu, Chad Hancock
1Metabolism and Cancer Susceptibility Section, Basic Research Laboratory, Center for Cancer Research, Frederick National Laboratory for Cancer Research Frederick, MD, USA.
Cancer metabolism research reveals MYC oncogene activates glutamine-to-proline pathway, impacting cell regulation and offering new therapeutic targets for cancer treatment.
Area of Science:
- Metabolic pathways in cancer
- Amino acid metabolism
- Cellular regulation
Background:
- Cancer cells alter glucose and glutamine metabolism for growth.
- Peripheral metabolic pathways, including non-essential amino acids, are increasingly recognized for regulatory roles.
- The proline biosynthetic pathway's link to glucose metabolism and its activation by p53 in apoptosis were previously proposed.
Purpose of the Study:
- To investigate the role of the glutamine-to-proline pathway in cancer.
- To explore the regulation of proline metabolism by oncogenes.
- To identify novel therapeutic targets in cancer metabolism.
Main Methods:
- Analysis of metabolic pathways.
- Investigation of oncogene-driven metabolic alterations.
- Study of amino acid biosynthesis and degradation.
Main Results:
- The oncogene MYC markedly activates the pathway from glutamine to proline.
- Proline biosynthesis and its metabolic interlock with glucose metabolism are dependent on this MYC-activated pathway.
- This highlights a new regulatory axis for proline in cancer.
Conclusions:
- The glutamine-to-proline pathway, activated by MYC, represents a significant regulatory axis in cancer metabolism.
- Targeting this pathway offers potential new strategies for cancer therapy.
- Understanding proline's role in cancer provides novel therapeutic avenues.
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
